Article Details
Retrieved on: 2024-07-27 12:00:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
JMP Securities analyst Reni Benjamin lowered the firm's price target on Cue Biopharma to $2 from $15 and keeps an Outperform rating on the shares.
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here